Canada extends GMP to cover active pharmaceutical ingredients

05/14/2013 | In-PharmaTechnologist.com

Canada has issued new regulations, effective in November, that will establish good manufacturing practice requirements for all companies that manufacture, package/label, test or import APIs. Labeling will need to ensure that APIs can be traced from the original manufacturer to the maker of the drug in dosage form.

View Full Article in:

In-PharmaTechnologist.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Food & Drug Associate
Confidential
Washington, D.C., DC